Abstract
Electrical remodeling paradigm has important implications for the understanding of atrial fibrillation (AF) and improvement of current treatment. Cardiomyocyte Ca2+ overload is generally accepted as the initiating signal for the tachycardia-induced changes in atrial electrical properties (electrical remodeling). The precise role of cardiomyocyte Ca2+ overload in AF-related ion channel alterations that contribute to AF maintenance is not fully understood. Clinically, patients with AF are often treated with Ca2+ channel blockers such as verapamil to control their ventricular rate and to improve the success rate of cardioversion procedures. However, verapamil may produce an increased L-type Ca2+ channel current (ICa,L) that may reinforce Ca2+ overload thereby promoting AF in the atrium. Ca2+ channel blockers which target T-type Ca2+ channels in addition to ICa,L (for instance, efonidipine) may be more efficient at preventing Ca2+ overload and arrhythmogenic electrical remodeling, but the potential benefits of these drugs have usually been tested in experimental models where drug administration preceded the initiation of electrical remodeling. Studies in animal models with established atrial tachycardia remodeling and in patients with AF are clearly warranted to prove the efficacy of Ca2+ channel blockers that additionally target T-type Ca2+ channels.
References
Benardeau A, Fareh S, Nattel S (2001) Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs. Cardiovasc Res 50:85–96
Bosch RF, Scherer CR, Rüb N, Wöhrl S, Steinmeyer K, Haase H, Busch AE, Seipel L, Kühlkamp V (2003) Molecular mechanisms of early electrical remodeling: transcriptional downregulation of ion channel subunits reduces ICa,L and Ito in rapid atrial pacing in rabbits. J Am Coll Cardiol 41:858–869
Christ T, Boknik P, Wöhrl S, Wettwer E, Graf EM, Bosch RF, Knaut M, Schmitz W, Ravens U, Dobrev D (2004) Reduced L-type Ca2+ current density in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 110:2651–2657
Dobrev D (2006) Electrical remodeling in atrial fibrillation. Herz Cardiovasc Dis 31:108–112
Dobrev D, Milde A, Andreas A, Ravens U (1999) The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum. Br J Pharmacol 127:576–582
Fareh S, Benardeau A, Nattel S (2001) Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs. Cardiovasc Res 49:762–770
Furukawa T, Nukada T, Miura R, Ooga K, Honda M, Watanabe S, Koganesawa S, Isshiki T (2005) Differential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (alpha1G) expressed in Xenopus oocytes. J Cardiovasc Pharmacol 45:241–246
Goette A, Arndt M, Röcken C, Staack T, Bechtloff R, Reinhold D, Huth C, Ansorge S, Klein HU, Lendeckel U (2002) Calpains and cytokines in fibrillating human atria. Am J Physiol Heart Circ Physiol 283:H264–H272
Green EM, Barrett CF, Bultynck G, Shamah SM, Dolmetsch RE (2007) The tumor suppressor eIF3e mediates calcium-dependent internalization of the L-type calcium channel Cav1.2. Neuron 55:615–632
Greiser M, Halaszovich CR, Frechen D, Boknik P, Ravens U, Dobrev D, Lückhoff A, Schotten U (2007) Pharmacological evidence for altered src-kinase regulation of ICa,L in patients with chronic atrial fibrillation. Naunyn Schmiedeberg’s Arch Pharmacol 375:383–392
Laszlo R, Winkler C, Wöhrl S, Wessel RE, Laszlo S, Busch MC, Schreieck J, Bosch RF (2007) Effect of verapamil on tachycardia-induced early cellular electrical remodeling in rabbit atrium. Naunyn Schmiedeberg’s Arch Pharmacol [Sep 15; Epub ahead of print]
Ohashi N, Mitamura H, Tanimoto K, Fukuda Y, Kinebuchi O, Kurita Y, Shiroshita-Takeshita A, Miyoshi S, Hara M, Takatsuki S, Ogawa S (2004) A comparison between calcium channel blocking drugs with different potencies for T- and L-type channels in preventing atrial electrical remodeling. J Cardiovasc Pharmacol 44:386–392
Qi X, Yeh YH, Xiao L, Nattel S (2006) Molecular mechanisms of tachycardia-dependent atrial remodeling probed in a novel in vitro model. Circulation 114(Suppl II):II–292
Rossow CF, Dilly KW, Santana LF (2006) Differential calcineurin/NFATc3 activity contributes to the Ito transmural gradient in the mouse heart. Circ Res 98:1306–1313
Schroder E, Magyar J, Burgess D, Andres D, Satin J (2007) Chronic verapamil treatment remodels ICa,L in mouse ventricle. Am J Physiol Heart Circ Physiol 292:H1906–H1916
Sun H, Chartier D, Leblanc N, Nattel S (2001) Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. Cardiovasc Res 49:751–761
Tessier S, Karczewski P, Krause EG, Pansard Y, Acar C, Lang-Lazdunski M, Mercadier JJ, Hatem SN (1999) Regulation of the transient outward K+ current by Ca2+/calmodulin-dependent protein kinases II in human atrial myocytes. Circ Res 85:810–819
Waldegger S, Niemeyer G, Morike K, Wagner CA, Suessbrich H, Busch AE, Lang F, Eichelbaum M (1999) Effect of verapamil enantiomers and metabolites on cardiac K+ channels expressed in Xenopus oocytes. Cell Physiol Biochem 9:81–89
Acknowledgements
The author’s research is supported by the German Federal Ministry of Education and Research (BMBF) through the Atrial Fibrillation Competence NETwork (AFNET, grant 01Gi0204) and by a grant of Fondation Leducq.
Conflict of Interests
The author has no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dobrev, D. Cardiomyocyte Ca2+ overload in atrial tachycardia: is blockade of L-type Ca2+ channels a promising approach to prevent electrical remodeling and arrhythmogenesis?. Naunyn-Schmied Arch Pharmacol 376, 227–230 (2007). https://doi.org/10.1007/s00210-007-0199-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-007-0199-x